Erratum: Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs

被引：0
作者：
Delphine Charvin
Rossella Medori
Robert A. Hauser
Olivier Rascol
机构：
来源：
Nature Reviews Drug Discovery | 2018年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Nature Reviews Drug Discovery 17, 10.1038/nrd.2018.136 (2018) In the original version of Figure 3, a dopamine D2 receptor had been positioned incorrectly and has now been moved to the correct presynaptic position on the dopaminergic neurons projecting to the basal ganglia motor circuit. In addition,the two Figure 2 citations that appeared on page 14 were incorrect and have now been changed to Figure 3.
引用
收藏
页码：844 / 844
相关论文
共 50 条
  • [1] Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs
    Charvin, Delphine
    Medori, Rossella
    Hauser, Robert A.
    Rascol, Olivier
    NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (11) : 804 - 822
  • [2] Schizophrenia and Parkinson's disease: Selected therapeutic advances beyond the dopaminergic etiologies
    Ghanemi, Abdelaziz
    ALEXANDRIA JOURNAL OF MEDICINE, 2013, 49 (04) : 287 - 291
  • [3] Dopaminergic drugs in development for Parkinson's disease
    Korczyn, AD
    PARKINSON'S DISEASE, 2003, 91 : 267 - 271
  • [4] Antimicrobial drugs for Parkinson's disease: Existing therapeutic strategies and novel drugs exploration
    Fu, Mengjie
    Wang, Qiuchen
    Gao, Lihui
    Yuan, Xin
    Wang, Ju
    AGEING RESEARCH REVIEWS, 2024, 99
  • [5] Parkinson's disease, dopaminergic drugs and the plant world
    Kempster, Peter
    Ma, Andrew
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [6] Treatment of Parkinson disease: therapeutic reserve of the dopaminergic agonist
    Linazasoro, G.
    van Blercom, N.
    NEUROLOGIA, 2006, 21 (07): : 365 - 375
  • [7] Therapeutic strategies in Parkinson's disease
    Jankovic, Joseph
    GERIATRICS-US, 2006, 61 : 3 - U1
  • [8] Therapeutic Strategies in Parkinson's Disease
    Bharath, Muchukunte M. S.
    RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY, 2008, 2 (02) : 135 - 147
  • [9] Therapeutic strategies in Parkinson's disease
    Colombat, Sebastien
    Boulin, Mathieu
    ACTUALITES PHARMACEUTIQUES, 2020, 59 (595): : 25 - 28
  • [10] Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease
    O'Suilleabhain, PE
    Dewey, RB
    ARCHIVES OF NEUROLOGY, 2002, 59 (06) : 986 - 989
12345